TBA
Abstract
TBA
Part of UK virtual operator algebra seminar: https://sites.google.com/view/uk-operator-algebras-seminar/home
TBA
Part of UK virtual operator algebra seminar: https://sites.google.com/view/uk-operator-algebras-seminar/home
There are many constructions that yield C*-algebras. For example, we build them from groups, quantum groups, dynamical systems, and graphs. In this talk we look at C*-algebras that arise from a certain type of game. It turns out that the properties of the underlying game gives us very strong information about existence of traces of various types on the game algebra. The recent solution of the Connes Embedding Problem arises from a game whose algebra has a trace but no hyperlinear trace.
Assumed knowledge: Familiarity with tensor products of Hilbert spaces, the algebra of a discrete group, and free products of groups.
Part of UK virtual operator algebras seminar: https://sites.google.com/view/uk-operator-algebras-seminar/home
In this talk, we will review the notion of non-invertible symmetries and we will study adjoint QCD in two dimensions. It turns out that this theory has a plethora of such symmetries which require deconfinement in the massless case. When a mass or certain quartic interactions are tunrned on, these symmetries are broken and the theory confines. In addition, we will use these symmetries to calculate the string tension for small mass and make some comments about naturalness along the RG flow.
In 2010, Hrushovski--Loeser studied the homotopy type of the Berkovich analytification of a quasi-projective variety over a valued field. In this talk, we explore the extent to which some of their results might hold in a relative setting. More precisely, given a morphism of quasi-projective varieties over a valued field, we ask if we might construct deformation retractions of the analytifications of the source and target which are compatible with the analytification of the morphism and whose images are finite simplicial complexes.
There has been a surge of interest in machine learning in the past few years, and deep learning techniques are more and more integrated into
the way we do quantitative science. A particularly exciting case for deep learning is molecular physics, where some of the "superpowers" of
machine learning can make a real difference in addressing hard and fundamental computational problems - on the other hand the rigorous
physical footing of these problems guides us in how to pose the learning problem and making the design decisions for the learning architecture.
In this lecture I will review some of our recent contributions in marrying deep learning with statistical mechanics, rare-event sampling
and quantum mechanics.
We propose a mathematical model that unifies the psychiatric concepts of drug-induced incentive salience (IST), reward prediction error
(RPE) and opponent process theory (OPT) to describe the emergence of addiction within substance abuse. The biphasic reward response (initially
positive, then negative) of the OPT is activated by a drug-induced dopamine release, and evolves according to neuro-adaptative brain
processes. Successive drug intakes enhance the negative component of the reward response, which the user compensates for by increasing the
drug dose. Further neuroadaptive processes ensue, creating a positive feedback between physiological changes and user-controlled drug
intake. Our drug response model can give rise to qualitatively different pathways for an initially naive user to become fully addicted. The
path to addiction is represented by trajectories in parameter space that depend on the RPE, drug intake, and neuroadaptive changes.
We will discuss how our model can be used to guide detoxification protocols using auxiliary substances such as methadone, to mitigate withdrawal symptoms.
If this is useful here are my co-authors:
Davide Maestrini, Tom Chou, Maria R. D'Orsogna
The talk will discuss the use of mathematical models for understanding targeted cancer therapies. One area of focus is the treatment of chronic lymphocytic leukemia with tyrosine kinase inhibitors. I will explore how mathematical approaches have helped elucidate the mechanism of action of the targeted drug ibrutinib, and will discuss how evolutionary models, based on patient-specific parameters, can make individualized predictions about treatment outcomes. Another focus of the talk is the use of oncolytic viruses to kill cancer cells and drive cancers into remission. These are viruses that specifically infect cancer cells and spread throughout tumors. I will discuss mathematical models applied to experimental data that analyze virus spread in a spatially structured setting, concentrating on the interactions of the virus with innate immune mechanisms that determine the outcome of virus spread.